Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 62

1.

Manidipine: an antihypertensive drug with positive effects on metabolic parameters and adrenergic tone in patients with diabetes.

SaizSatjes M, Martinez-Martin FJ.

Drugs Context. 2018 Jan 3;7:212509. doi: 10.7573/dic.212509. eCollection 2018. Review.

2.

Pakistan's Recommendations for Optimal Management of diabetes from Primary to Tertiary care level (PROMPT).

Shera AS, Basit A, Team P.

Pak J Med Sci. 2017 Sep-Oct;33(5):1279-1283. doi: 10.12669/pjms.335.13665.

3.

Amlodipine in hypertension: a first-line agent with efficacy for improving blood pressure and patient outcomes.

Fares H, DiNicolantonio JJ, O'Keefe JH, Lavie CJ.

Open Heart. 2016 Sep 28;3(2):e000473. eCollection 2016.

4.

Association between renin and atherosclerotic burden in subjects with and without type 2 diabetes.

Gonçalves I, Edsfeldt A, Colhoun HM, Shore AC, Palombo C, Natali A, Fredrikson GN, Björkbacka H, Wigren M, Bengtsson E, Östling G, Aizawa K, Casanova F, Persson M, Gooding K, Gates P, Khan F, Looker HC, Adams F, Belch J, Pinnola S, Venturi E, Kozakova M, Gan LM, Schnecke V, Nilsson J; SUMMIT consortium.

BMC Cardiovasc Disord. 2016 Sep 5;16(1):171. doi: 10.1186/s12872-016-0346-8.

5.

Cardiovascular and Renal Outcomes of Renin-Angiotensin System Blockade in Adult Patients with Diabetes Mellitus: A Systematic Review with Network Meta-Analyses.

Catalá-López F, Macías Saint-Gerons D, González-Bermejo D, Rosano GM, Davis BR, Ridao M, Zaragoza A, Montero-Corominas D, Tobías A, de la Fuente-Honrubia C, Tabarés-Seisdedos R, Hutton B.

PLoS Med. 2016 Mar 8;13(3):e1001971. doi: 10.1371/journal.pmed.1001971. eCollection 2016 Mar. Review. Erratum in: PLoS Med. 2016 Jun;13(6):e1002064.

6.

Diabetes mellitus as a compelling indication for use of renin angiotensin system blockers: systematic review and meta-analysis of randomized trials.

Bangalore S, Fakheri R, Toklu B, Messerli FH.

BMJ. 2016 Feb 11;352:i438. doi: 10.1136/bmj.i438. Review. Erratum in: BMJ. 2016;352:i1525.

7.

Kidney measures with diabetes and hypertension on cardiovascular disease: the Atherosclerosis Risk in Communities Study.

Alexander N, Matsushita K, Sang Y, Ballew S, Mahmoodi BK, Astor BC, Coresh J.

Am J Nephrol. 2015;41(4-5):409-17. doi: 10.1159/000433450. Epub 2015 Jun 30.

8.

Multi-modal intervention to reduce cardiovascular risk among hypertensive older adults: Design of a randomized clinical trial.

Buford TW, Anton SD, Bavry AA, Carter CS, Daniels MJ, Pahor M.

Contemp Clin Trials. 2015 Jul;43:237-42. doi: 10.1016/j.cct.2015.06.019. Epub 2015 Jun 23.

9.

Uptitrating amlodipine significantly reduces blood pressure in diabetic patients with hypertension: a retrospective, pooled analysis.

Jeffers BW, Bhambri R, Robbins J.

Vasc Health Risk Manag. 2014 Nov 14;10:651-9. doi: 10.2147/VHRM.S64511. eCollection 2014.

10.

Effects of ACEI/ARB in hypertensive patients with type 2 diabetes mellitus: a meta-analysis of randomized controlled studies.

Hao G, Wang Z, Guo R, Chen Z, Wang X, Zhang L, Li W.

BMC Cardiovasc Disord. 2014 Oct 25;14:148. doi: 10.1186/1471-2261-14-148. Review.

11.

Effects of the fixed combination of manidipine plus delapril in the treatment of hypertension inadequately controlled by monotherapy with either component: a phase III, multicenter, open-label, clinical trial.

Zoppi A, Mugellini A, Preti P, Rinaldi A, Celentano A, Arezzi E, Alberici M, Fogari R.

Curr Ther Res Clin Exp. 2003 Jul;64(7):422-33. doi: 10.1016/S0011-393X(03)00109-7.

12.

Importance of cardiovascular disease risk management in patients with type 2 diabetes mellitus.

Lorber D.

Diabetes Metab Syndr Obes. 2014 May 23;7:169-83. doi: 10.2147/DMSO.S61438. eCollection 2014. Review.

13.

Type 2 diabetes mellitus and hypertension: an update.

Lastra G, Syed S, Kurukulasuriya LR, Manrique C, Sowers JR.

Endocrinol Metab Clin North Am. 2014 Mar;43(1):103-22. doi: 10.1016/j.ecl.2013.09.005. Epub 2013 Dec 12. Review.

14.
15.

Prescription Pattern of Antihypertensive Agents in T2DM Patients Visiting Tertiary Care Centre in North India.

Dhanaraj E, Raval A, Yadav R, Bhansali A, Tiwari P.

Int J Hypertens. 2012;2012:520915. doi: 10.1155/2012/520915. Epub 2012 Dec 18.

16.

Standards of medical care in diabetes--2013.

American Diabetes Association.

Diabetes Care. 2013 Jan;36 Suppl 1:S11-66. doi: 10.2337/dc13-S011. No abstract available.

17.

The past, present and future of renin-angiotensin aldosterone system inhibition.

Mentz RJ, Bakris GL, Waeber B, McMurray JJ, Gheorghiade M, Ruilope LM, Maggioni AP, Swedberg K, Piña IL, Fiuzat M, O'Connor CM, Zannad F, Pitt B.

Int J Cardiol. 2013 Sep 1;167(5):1677-87. doi: 10.1016/j.ijcard.2012.10.007. Epub 2012 Oct 31. Review.

18.

Diabetes: treating hypertension.

Vijan S.

BMJ Clin Evid. 2012 Mar 28;2012. pii: 0608. Review.

19.

Cardio classics revisited: focus on the role of amlodipine.

Owen AJ, Reid CM.

Integr Blood Press Control. 2012;5:1-7. doi: 10.2147/IBPC.S9335. Epub 2012 Jan 6.

20.

Standards of medical care in diabetes--2012.

American Diabetes Association.

Diabetes Care. 2012 Jan;35 Suppl 1:S11-63. doi: 10.2337/dc12-s011. Review. No abstract available.

Supplemental Content

Support Center